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Tissue-Specific Progenitor and Stem Cells
The Infrapatellar Fat Pad as a Source of Perivascular
StemCellsWith Increased Chondrogenic Potential for
Regenerative Medicine
PAUL HINDLE, NUSRAT KHAN, LEELA BIANT, BRUNO PE´AULT
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ABSTRACT
Perivascular stem cells (PSCs) are the natural ancestors ofmesenchymal stem cells (MSCs) and are the
stem cells responsible for homeostasis and repair in vivo. Prospectively identified and isolated PSCs
have demonstrated increased plasticity and osteogenic potential. Cells from the infrapatellar fat pad
(IFP) have demonstrated increased chondrogenic potential comparedwith those from subcutaneous
fat. This research assessed the chondrogenic potential of IFP PSCs compared with MSCs from the IFP
and bone marrow. Immunohistochemistry demonstrated the location of perivascular markers
(CD146, CD34, neural/glial antigen 2 [NG2], platelet-derived growth factor receptor-b [PDGFRb],
anda-smoothmuscle actin [a-SMA]) in relation toendothelialmarkers (CD31, CD144, vonWillebrand
factor [vWF]). Pericytes and adventitial cells were isolated from the stromal vascular fraction (3.8%
and 21.2%, respectively) using flow cytometrywith a viability of 88%. Themean numbers of pericytes
and adventitial cells isolatedwere4.66 2.23 104 and 16.26 3.23 104, respectively, equating to 7.96
4.43 103 and 20.86 4.33 103 cells per gram of harvested tissue. Fluorescence-activated cell sorting
demonstrated that cultured PSCs were CD44+CD90+CD105+; polymerase chain reaction and immuno-
cytochemistry demonstrated that pericytes retained their CD146+ phenotype and expressed the peri-
cyte markers PDGFRb and NG2. Differentiation was confirmed using histochemical stains and genetic
expression. Using a pellet model, the IFP PSCs and theMSCs generated significantly more extracellular
matrix thanbonemarrowMSCs (p< .001andp= .011, respectively). The IFPPSCsgenerated significantly
moreextracellularmatrix than IFPMSCs (p= .002).Micromassculturedemonstrated thatdifferentiated
PSCswereupregulatedcomparedwithMSCs forCOL2A1,ACAN, andSOX9expressionby factorsof4.86
1.3, 4.360.9, and7.06 1.7, respectively. The IFPwasa significantly better sourceof chondrogenic stem
cells comparedwith bonemarrow. PSCs generated significantlymore extracellularmatrix than culture-
derived MSCs. STEM CELLS TRANSLATIONALMEDICINE 2016;5:1–11
SIGNIFICANCE
This paper presents data on the use of the infrapatellar fat pad as a source of perivascular stem cells
for tissue engineering. It also presents quantitative data on the chondrogenic potential of perivascu-
lar stem cells and their superiority over culture-derived MSCs.
INTRODUCTION
Perivascular stem cells (PSCs) have been identi-
fied as natural ancestors of culture-derived mes-
enchymal stem cells (MSCs) [1] and are responsible
for homeostasis and regeneration in vivo [2]. PSCs
consist of pericytes, which typically reside around
smaller blood vessels such as capillaries, venules,
and arterioles, and adventitial cells, which are found
around larger arteries and veins [1, 3]. It has been
demonstrated that adventitial cells can produce peri-
cytes;wheneitherofthesecellpopulationsareplaced
in culture, they lead to cell populations that are indis-
tinct from what are commonly termed MSCs [2].
PSCshaveshownosteogenic,chondrogenic,adi-
pogenic, and myogenic potential, but this has only
been quantified for osteogenesis [4–6]. Pericyte-
like progenitors have been shown to be more
plastic with greater immaturity and engraft-
ment potential compared with MSCs [1, 2, 7],
suggesting they would be a better source of
stem cells for use in tissue regeneration and en-
gineering. Chondrogenesis was demonstrated
by Farrington-Rock et al. using bovine retinal
pericytes [1, 3, 8]. In humans, the demonstra-
tion of the chondrogenic potential of pericytes
has been limited to Alcian blue staining on pel-
let cultures [1, 3]; there are no data quantifying
or comparing the chondrogenic potential of
pericytes to that of culture-derived MSCs.
The in vivo location of chondroprogenitor
cells is still debated, with some believing they
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come from the tissues within the joint and others arguing that
they come from subchondral bone. The infrapatellar fat pad
(IFP) is an intra-articular but extrasynovial structure (Fig. 1A) ad-
jacent to the articular cartilage [9]. CD146 has been implicated as
a marker found on chondroprogenitor cells within articular carti-
lage [10]. Khan et al. identified 3G5-positive perivascular stem
cells on tissue sections of the IFP but found that only a small pro-
portion of cells cultured from the IFP maintained this phenotype
[11]. The proximity of the infrapatellar fat makes it a candidate
for the origin of chondroprogenitor cells. Stem cells derived
from the IFP, therefore, could have a greater affinity for carti-
lage regeneration.
Previous research into PSCs has routinely used subcutaneous
fat from the abdomen because this is easily obtained as waste
material from patients undergoing elective procedures. The
structure and content of adipose tissue varies depending on its
location [12], as does the regenerative potential of the harvested
MSCs [13, 14]. The IFP has demonstrated increased chondrogenic
potential compared with subcutaneous abdominal fat from
matched patient samples [15]. The IFP is also different in that
harvesting it from within the joint also includes the synovial
membrane.
The authors are not aware of any published data demonstrat-
ing that the IFP is a viable source for harvesting PSCs for use in
tissue engineering. There are also, to our knowledge, no data
quantifying and comparing the chondrogenic potential of PSCs
with that of MSCs. Research has typically used IFP samples from
patients undergoing knee arthroplasty who are typically in their
sixth and seventh decades. Data from these older patients requir-
ing treatment for osteoarthritis may not be applicable to those
with focal cartilage defects—themain group suitable for cartilage
regeneration procedures and who are typically in their third and
fourth decades.
Articular cartilage damage occurs through developmental
conditions, trauma, and early degeneration. It typically occurs
in younger patients and can cause similar levels of pain andmorbid-
ity as end-stage arthritis [16]. This has a significant effect on the pa-
tient’s ability to work, exercise, and undertake social activities.
Articular cartilage defects are incapable of self-repair andonce they
reach a critical size, theywill degenerate to end-stage arthritis [17].
The cost of treating these problems is estimated to be $40 billion
per annum in the U.S. alone. The aims of cartilage repair surgery
are to alleviate pain, maximize function of the joint, and prevent
progression to end-stage osteoarthritis. This is of vital impor-
tance in young adults because the inevitable degeneration is
currentlymanagedwith surgical joint replacement, an unattrac-
tive option in younger patients because of their high functional
demands and the lower longevity of the implant. The ideal treat-
ment for these patients would be regeneration of the hyaline
cartilage.
The primary aim of this studywas to assess the IFP as a source
for prospectively isolating PSCs for tissue engineering, particu-
larly cartilage regeneration. Additional aims were to determine
if there were differences in chondrogenic potential between
the IFP and bone marrow, and between PSCs and MSCs from
the IFP.Wealso investigatedwhether samples couldbeharvested
arthroscopically from younger patients and whether these
samples differed from those from older patients undergoing
arthroplasty, because this has direct implications for orthopedic
surgeons harvesting their own samples for cartilage regeneration
in the knee.
MATERIALS AND METHODS
Tissue Harvest and Cell Isolation
Collection, storage, and use of tissue samples were approved by
the South-East Scotland Research Ethics Committee (reference
no. 10/S1103/45). Infrapatellar fat pad excised as part of total
knee replacement (TKR; Fig. 1B) or arthroscopic anterior cruciate
ligament reconstruction (ACL; Fig. 1C) were collected and trans-
ported to the laboratory in sterile Dulbecco’sModified EagleMe-
dium (DMEM) supplemented with 10% fetal bovine serum (FBS)
and 1% penicillin-streptomycin (PS).
Tissue samples were mechanically disrupted to ensure they
were less than 1 mm3 (Fig. 1C, 1E) and were covered with diges-
tionmedium (DMEMsupplementedwith 10%FBS, 1%PS, and 1%
collagenase II [Thermo Fisher Scientific Life Sciences, Waltham,
MA, http://www.thermofisher.com]). Samples were digested in
a shaking water bath at 37°C and 150 rpm for 40 minutes. The di-
gestsweremixedwith an equal volumeofDMEMand then centri-
fuged at 1,800 rpm for 10 minutes. The supernatant, containing
adipocytes and oily fat, was aspirated and discarded. The pellets
were resuspended in 25 ml 2% FBS/PBS (5 mM EDTA). The tissue
suspensions were successively filtered through a 200-mm nylon
mesh and then 100-, 70-, and 40-mm cell strainers. The strained
suspensions were centrifuged at 1,500 rpm for 10 minutes. The
supernatant was aspirated and discarded, and the pellets were
resuspended for flow cytometry to isolate PSCs. To obtain IFP
culture-derived MSCs, this cell suspension was placed into 10 ml of
culturemedium in aT75 flask. Bonemarrowcollected from thedistal
femur of patients undergoing knee replacement surgery was placed
directly into 10 ml of culture medium in a T75 flask to obtain MSCs.
The MSC cultures had their medium replaced at 24 hours and all
adherent cells were left to proliferate.
Histology and Immunohistochemistry
Tissue sampleswere resected so that theywere less than2cm3, to
ensure rapid and complete fixation in 4% formalin. Fixed tissue
was placed in Tissue-Tek cassettes (Sakura Finetek, Torrance,
CA, http://www.sakura-americas.com) and processed using
a Leica ASP processor (Leico Biosystems, Nussloch, Germany,
http://www.leicabiosystems.com) using sequential alcohol, xy-
lene, and paraffin wax steps. Tissue was subsequently embedded
into molten wax, allowed to solidify on a cold plate, and cut into
7-mm thick sections. Sections were incubated at 55°C overnight,
dewaxed (xylene for 5 minutes, 3 times), and rehydrated (100%
ethanol for 2 minutes, 3 times; then 95%, 80%, and 50% ethanol
for 2minutes each; and thenwashedunder runningwater). Slides
were stainedas described in thenext paragraph, thendehydrated
(in 50%,80%, and95%ethanol for30 seconds each, and100%eth-
anol for 2 minutes, 3 times), and mounted using xylene.
Sections were incubated in Harris hematoxylin (Sigma-
Aldrich, St. Louis, MO, http://www.sigmaaldrich.com) for 5 min-
utesandthenwashedunderrunningwater.Theyweredifferentiated
in 1% hydrochloric acid in ethanol and transferred to a dish of
Scott’s tap water substitute for 2 minutes until the tissue sec-
tions turned blue. Slides were counterstained in eosin for 2
minutes and were washed briefly under running water. Picro-
sirius red (PSR) solution was made using sirius red F3B (0.1%)
in saturated aqueous picric acid. Sections were placed in PSR
solution for 2 hours, removed, and washed in running water
for 30 seconds.
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Tyramide signal amplification was carried out using a Leica
BOND-MAX staining robot (Leica Biosystems). Slideswere initially
blocked with hydrogen peroxidase (1:10 in BOND wash [BW]) for
10 minutes and then in serum for 10 minutes (type depended on
secondary antibody host species). Sections were stainedwith the
primary antibody for 30 minutes (CD31 [catalog no. ab28364],
CD34 [catalog no. ab8536], CD146 [catalog no. ab134065], all
Abcam, Cambridge, MA, http://www.abcam.com; neural/
glial antigen 2 [NG2; catalog no. 554275], BD, Franklin Lakes,
NJ, http://www.bd.com; von Willebrand factor [vWF; catalog
no. V2700-01C], US Biological, Salem, MA, https://www.usbio.net)
followed by a horseradish peroxidase secondary for 30 minutes
(1:50dilution in serum,goat anti-rabbit [catalogno. ab7171;Abcam]
and goat anti-mouse [catalog no. ab6823; Abcam]). Tyramide am-
plification was carried out for 10 minutes (1:50 in own diluent)
using fluorescein isothiocyanate (FITC), cyanine (Cy) 3, and Cy5
tyramide kits, depending on the number antibodies required
(catalog nos. NEL741B001KT, NEL744B001KT, and NEL745B001KT,
respectively; Perkin Elmer,Waltham,MA, http://www.perkinelmer.
com) followed by 49,6-diamidino-2-phenylindole (DAPI) staining for
10 minutes (1:1,000 in BW).
Histochemical staining was imaged using a brightfield set-
ting and color camera with a Zeiss Observer microscope (Zeiss
International, Jena, Germany, http://www.zeiss.com). AnOlym-
pus BX61 fluorescence microscope (Olympus, Tokyo, Japan,
http://www.olympus-global.com) was used to sequentially re-
cord the emission from the individual fluorophores used for im-
munohistochemistry; these were subsequently merged to form
a composite image. Controls using isotypes were imaged under
identical conditions.
Flow Cytometry
The cells were blocked in 10% mouse serum in PBS and left at
room temperature (RT) for 20 minutes—100 ml for analysis and
500 ml for cell sorting. Antibodies were added to the cell suspen-
sion in the dark at a dilution of 1:100 unless otherwise stated. The
following antibodies from BDwere used for cell sorting: CD31-PE
(BD340297), CD34-FITC (BD555821), CD45-PE-Cy7 (BD557748),
and CD146-AF647 (BD562230). The additional antibodies used
when assessing cultured cells included CD34-PE (catalog no.
R1725; Agilent Technologies; Santa Clara, CA, http://www.
agilent.com); and from BD: CD44-AF700 (BD561289), CD56-
PE-Cy7 (BD560916), CD90-FITC (BD555595), CD105-PE-Cf594
(BD562380), and CD144-PerCP-Cy5.5 (BD561566). The cells
were incubated for 20minutes on ice in the dark. The cells were
washed in 2 ml of PBS and centrifuged at 1,000 rpm for 5 min-
utes. The supernatant was aspirated and discarded, and the
pellet resuspended in 2% FBS/PBS,with 300ml used for analysis
and 500 ml for cell sorts.
For each antibody, a compensation tube was set up using a
single drop of positive compensation beads (BD) diluted with
70 ml of 2% FBS/PBS and stained in an identical manner to
the cells. These were resuspended in a final volume of 270 ml
and a drop of negative control beads was added just before
fluorescence-activated cell sorting (FACS) analysis or sorting.
Gates were set using negative controls to determine the level
of true-positive staining.
Cell Culture
FACS sorted cells were collected in 300 ml of endothelial cell
growth medium (EGM-2; Lonza, Basel, Switzerland, http://
www.lonza.com) as pericytes (CD312CD342CD452CD146+)
and adventitial cells (CD312CD34+CD452CD1462). Wells and
flasks were precoated with 0.2% (weight per volume) gelatin
(EMD Millipore, Billerica, MA, http://www.emdmillipore.com)
for 10 minutes at 4°C. Cells were plated at a density of approxi-
mately 4 3 104 per cm2 in EGM-2 and cultured at 37°C, 5%
CO2. TheEGM-2mediumwas changed after 7days and thenevery
4 days after that until the cells reached 90%–100% confluence.
From passage 1 onward, all cells were cultured in DMEM/20%
FBS/1% PS. Cells were washed twice in PBS and then incubated
in 0.05% trypsin-EDTA at 37°C, 5% CO2 for 3–5 minutes until
.90% of the cells were mobilized. Complete medium was added
to the plate or flask and the cell suspension transferred to a 15-ml
centrifuge tube. The cells were pelleted by centrifuging at 1,000
rpm for 5minutes. The supernatant was aspirated and discarded,
Figure 1. Infrapatellar fat pad location and samples. (A): Sagittal magnetic resonance imaging scan of the knee showing the relationship of the infra-
patellar fatpad (IFP;white) to thearticular cartilage (black). (B,C):Excised IFP fromapatientundergoingkneearthroplasty (B)has the fat removed from
the fibrous tissue (C). (D, E): The arthroscopically harvested fat pad (D) was separated from the irrigation fluid before enzymatic digestion (E).
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and the pelletwas resuspended for further culture expansion, dif-
ferentiation, or flow cytometry.
Mesenchymal Differentiation
Monolayer differentiation was undertaken using 20wells of a 24-
well plate: 10 wells were used for growth medium (DMEM/10%
FBS/1%PS)and10fordifferentiationmedium(HyCloneAdvanceSTEM
osteogenic and adipogenic media; GE Healthcare Biosciences, Pitts-
burgh, PA, http://www.gelifesciences.com). Each set of 10wells was
split into 5 for ribonucleic acid (RNA) extraction and5 for histochem-
ical staining. The cells were diluted to a concentration of 23104 per
mland1mlwasaddedtoeachwell.Plateswere incubated at 37°C,
5% CO2, until they were 50%–70% confluent, at which point
they were considered to be at day 0 of the differentiation
course. Plates were taken at day 0 as controls. The medium
was removed from those plates undergoing differentiation
and replaced with 1 ml of either growth (DMEM/10% FBS/
1% PS) or differentiation medium. The media were changed
twice weekly for 21 days.
Three-dimensional pellet culture was used for chondrogenic
differentiation. After cell counting, the cells were resuspended in
either chondrogenicmedium (HyCloneAdvanceSTEM;GEHealth-
care Biosciences) or DMEM/10% FBS/1% PS at a concentration of
6 3 105 cells per ml, and 500 ml was pipetted into an individual
well of a 96-well V-bottom plate. Cells were pelleted by centrifu-
gation at 800 rpm for 5 minutes, followed by incubation at 37°C,
5%CO2. Six pellets were used for growthmedium controls and six
for differentiation medium. Of the six, three were used for RNA
extraction and three for histochemical staining. The medium
was changed twice weekly by centrifuging the plates at 800 rpm
for 5 minutes, and then the medium was aspirated, discarded,
and replacedwith freshmedium. Aftermediumchanges, the pellets
were gently agitated to ensure they were not adherent.
The micromasss cultures were based on the methods of Zhu
et al. [18]. The micromasses were formed by resuspending 5 3
105 cells in 30ml of chondrogenicmedium described by Kafienah
et al. [19]. The cell suspension was gently pipetted into the mid-
dle of a singlewell of a 24-well plate. The cellswere left overnight
at 37°C, 5% CO2, before adding an additional 1 ml of chondro-
genic medium. The medium was changed every 2–3 days for
21 days.
Histochemistry
For immunocytochemistry, the PBS was removed and the cells
permeabilizedwith 0.05%Triton-PBS for 3minutes at RT; the cells
werewashed three timeswith PBS and then blockedwith Protein
Block (Agilent Technologies) for 1hour atRT. Cellswerewashed in
PBS and then incubated with the primary antibody overnight
at 4°C. The following morning, the wells were washed 3 times
for 5 minutes—once with PBS-Tween and twice with PBS. Cells
were incubated with the secondary antibody for 1 hour at RT in
the dark. After a further three washes, the coverslips were re-
moved and any excess fluid removed. The coverslips were
mounted onto slides using DAPI fluoromount and allowed to
air dry for 1 hour in the dark before being fixed in place with
an adhesive. Cultured pericytes from five different patients
were analyzed using three different anti-CD146 antibodies
(clone OJ79c [catalog no. MCA2141F], BioRad Laboratories,
Hercules, CA, http://www.bio-rad.com; clone 541-10B2 [cata-
log no. 130-092-851], Miltenyi Biotec, San Diego, CA, http://
www.miltenyibiotec.com; clone P1H12 [catalog no. 563186],
BD Biosciences).
Osteogenic differentiation was determined by using Alizarin
red to form a birefringent complexwith calcium deposits. Alizarin
red solutionwasmadebyadding2gAlizarin redS (C.I. 58005)with
100 mL of distilled water (dH2O). This was thoroughly mixed and
the pH altered to 4.1–4.3 with 10% ammonium hydroxide. The
wells were stained with 1 ml of Alizarin red solution for approx-
imately 30minutes at RT to produce red-orange staining with cal-
cium. Excess stainwas removed bywashing four timeswith dH2O.
Adipogenic differentiation was assessed using Oil Red O. A
stock solution was prepared by mixing 0.7 g of Oil Red O (catalog
no. Sigma O-062; Sigma-Aldrich) with 200 ml of isopropanol. This
was stirred overnight and then passed through a 0.2-mm filter.
The stock solution was stored at 4°C. The working solution was
made by adding six parts stock solution to four parts dH2O. This
wasmixed and left at RT for 20minutes before being passed through
a 0.2-mm filter. The wells were washed twice with dH2O and then
dehydratedwith 60% isopropanol for 5minutes at RT. The isopropa-
nolwas removedand thewellsdriedwithoutwashing. The cellswere
stained with 1 ml of Oil Red O solution for 10 minutes at RT. Excess
stain was removed by washing four times with dH2O.
Chondrogenic differentiation was indicated by Alcian blue
staining for proteoglycans. Slides or wells were incubated with
acetic acid for 3minutes at RT followed by Alcian blue for 30min-
utes at RT. Excess stain was removed using acetic acid and the
slides were washed three times with dH2O. Picrosirius red was
also used to determine collagen deposition.
RNA Extraction
RNA was extracted using TriZol (Thermo Fisher Scientific Life Sci-
ences) and phase separation followed by an RNeasy Micro Kit
(Qiagen, Hilden, Germany, https://www.qiagen.com). Samples
were stored in TriZol at 280°C so they could be analyzed under
identical conditions. Samples were thawed on ice and 200 ml of
chloroform was added per 1 ml of TRIzol; these were shaken by
hand for 20 seconds, left at RT for 2–3 min and centrifuged at
12,000 rpmand4°C for 20minutes. The top, clear layer containing
the RNA (approximately 200ml) was transferred to an RNase-free
2-ml Eppendorf tube and were then processed using the RNeasy
Micro Kit. The quantity and quality of RNA were measured using
NanoDrop (Thermo Fisher Scientific Life Sciences) with an RNA to
protein ratio of 1.8–2.0 equating to good quality RNA.
Superscript III reverse transcriptase was used to convert RNA
tocomplementary deoxyribonucleic acid (cDNA). A total of 500ng
to 5 mg was diluted to a total volume of 12 ml with RNAse-free
water. Then 1 ml of random primers and 1ml of 10 mM deoxynu-
cleotide mix were added. The mixture was denatured at 65°C for
5minutes and cooled on ice for at least 1minute. A cDNA synthe-
sis mix consisting 4 ml of first-strand buffer (53 concentration;
ThermoFisher Scientific Life Sciences), 1ml of 0.1Mdithiothreitol,
and 1 ml of Superscript III reverse transcriptase enzyme (Thermo
Fisher Scientific Life Sciences). cDNA was synthesized by incuba-
tion at 25°C for 10minutes, 50°C for 60minutes, and termination
of the reaction by heating to 70°C for 15 minutes. The cDNA was
cooled to 4°C and kept refrigerated for short-term use and at
220°C for longer-term storage.
Polymerase Chain Reaction
PCR primers were obtained from Bioline (London, U.K., http://www.
bioline.com) as a lyophilized powder and were reconstituted to a
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stock concentration of 100 mM. A working concentration of 10 mM
was made by adding 5 ml of left and 5 ml of right primers to 90 ml
of RNase-freewater. PCRwas performed usingMyTaq DNA polymer-
ase (Bioline).Thereactionmixtureconsistedof5ml ofMyTaqReaction
Buffer (53 concentration), 2ml of cDNA, 1ml of primers (10mM;
final concentration, 0.4mM), 0.25ml ofMyTaq DNApolymerase,
and 16.75 ml of RNase-free water.
The following primers were used for cell identity: CD31
(F:GAAGTACGGATCTATGACTCA, R:GTGAGTCACTTGAATGGTGCA);
CD34 (F:CATCACTGGCTATTTCCTGAT, R:AGCCGAATGTGTAAAG-
GACAG); CD45 (F:CATGTACTGCTCCTGATAAGA, R:GCCTACACTT-
GACATGCATAC); CD146 (F:AAGCAACCTCAGCCATGTCG, R: CTCG-
ACTCCACAGTCTGGGAC); NG2 (F:GCTTTGACCCTGACTATGTTG, R:
TCCAGAGTAGAGCTGCAGCA); platelet-derived growth factor b
(PDGFRb; F:CAGTAAGGAGGACTTCCTGGA, R:CCTGAGAGATCT-
GTGGTTCCA); and b-actin (ACTB; F:CCTCGCCTTTGCCGATCC,
R:GGAATCCTTCTGACCCATGC). The additional primers used
for differentiationwere as follows: collagen II (COL2A1; F:GGAAA-
CTTTGCTGCCCAGATG, R:TCACCAGGTTCACCAGGATTGC); SOX9
(F:ACATCTCCCCCAACGCCATC, R:TCGCTTCAGGTCAGCCTTGC);
aggrecan (ACAN; F:TGCGGGTCAACAGTGCCTATC, R:CACGATGCC-
TTTCACCACGAC), hyaluronan and proteoglycan link protein 1
(HAPLN1; F:CAACCAGTGCCTGTGTTTGG, R:TATTGGTCCCTGT-
GGGGTCT); superficial zone protein (SZP; F:CTCCTTTTTACAG-
CAAGGGCG, R:ATTATCCAGCCCGCTTCCAG); runt-related tran-
scription factor 2 (RUNX2; F:ACTGGGCCCTTTTTCAGA, R:GC-
GGAAGCATTCTGGAA); alkaline phosphatase live/bone/kidney (ALPL;
F:TCAGAAGCTCAACACCAACG, R:GTCAGGGACCTGGGCATT); osteo-
calcin (BGLAP; F:GCCTTTGTGTCCAAGC, R:GGACCCCACATCCATAG);
and peroxisome proliferator-activated receptor g (PPARG; F:
TGAATGTGAAGCCCATTGAA, R:CTGCAGTAGCTGCACGTGTT).
A 100-ml aliquot of 2% agarose gel was used to run PCR prod-
ucts with a molecular weight (MW) of less than 1 kb. Gels were
prepared by dissolving 2 g of agarose in 100 ml of 13 TAE buffer
(Tris base, acetic acid, and EDTA; TAE, 103 concentration, diluted
1:10 in dH2O; Thermo Fisher Scientific Life Sciences) by heating in
the microwave oven until all the agarose had dissolved. Then 10
ml of Gel Red was added (10,0003 concentration [catalog no.
41003; Biotium, Freemont, CA, https://biotium.com]). The gel
was loaded into a gel-casting tray; sample combs were inserted
andallowed to solidify atRT. The traywasplaced inanelectropho-
resis tank, covered in 13 TAE, and the combs removed. The cDNA
samples were diluted to 10ml with RNase-free water, mixed with
loading dye (2 ml, 63 concentration), and pipetted into a sample
well. A lowMWDNA ladder was run to allow the identification of
band sizes. The electrophoresis was run at 110V for 1 hour.
Quantitative Real-Time PCR
Quantitative real-timePCRwas carried out using a Lightcycler 480
(Roche Life Sciences, Indianapolis, IN, https://lifescience.roche.
com). cDNA was inserted into a 384-well plate in triplicate (2 ml
per well). Primer-specific mixtures were created for all samples
containing the following: 5ml of SYBR greenmaster mix (23 con-
centration; Roche Life Sciences), 2 ml of primers (right and left,
5 mM diluted to a final concentration of 1 mM), and 1 ml of
RNase-free water. The target gene primers used for quantitative
real-time PCR (qPCR) were as follows: collagen I (COL1A1; F:GGAA-
CACCTCGCTCTCCA, R:GGGATTCCCTGGACCTAAAG); COL2A1 (F:
CAGAGGGCAATAGCAGGTTC, R:AGTCTTGCCCCACTTACCG); SOX9 (F:
GTACCCGCACTTGCACAAC, R:TCTCGCTCTCGTTCAGAAGTC); and
ACAN (F:CCTCCCCTTCACGTGTAAAA, R:GCTCCGCTTCTGTAGTCTGC).
Figure 2. Immunohistochemistry and histology of the infrapatellar fat pad. Sections demonstrated perivascular staining of a smooth muscle
actin (A), CD146 (B, D–F), NG2 (C), CD34 (D–F), and PDGFRb (G). (B, C, E–G): The relationship to endothelial markers CD31 and vWF is shown.
(D–F): The locality of CD146 and CD34 is demonstrated. (H, I): Sections were stained with Picrosirius red (H) and hematoxylin and eosin (I) to
demonstrate the perivascular structures (H, I) aswell as the synovial membrane (I). DAPIwas used for nuclear staining and is shown in blue in all
images. Scale bar = 200mm (A, C, F); 50mm (B, D, E, G); 400mm (H); and 300mm (I). Abbreviations: aSMA,a-smoothmuscle actin; NG2, neural/
glial antigen 2; PDGFRb, platelet-derived growth factor receptor-b; vWF, von Willebrand factor.
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Three reference genes were tested to determine which was
the most stable: glyceraldehyde 3-phosphate dehydrogenase
(GAPDH; F:AGCCACATCGCTCAGACAC, R:GCCCAATACGACCAAATCC);
hypoxanthine-guanine phosphoribosyl transferase (HPRT1; F:
GTAGCCCTCTGTGTGCTCAA, R:TCACTATTTCTATTCATGCTTTGATG),
andACTB (F:ATTGGCAATGAGCGGTTC,R:CGTGGATGCCACAGGACT).
Then 8ml of the primermix was added to each of thewells. The
plate was sealed using a sealing foil and stored at 4°C before
analysis (less than 2 hours). The qPCR run protocol consisted
of an initial preincubation of 95°C for 5minutes followed by 45
amplification cycles (95°C for 10 seconds; 60°C for 10 seconds;
72°C for 5 secondswith a single detection).Melt curve analysis
was run by heating from 65°C to 97°C with 5 acquisitions per
degree centigrade.
Statistical Analyses
All statistical analyses were performed using Statistical Package
for the Social Sciences (version 21; IBM, Armonk, NY, http://
www.ibm.com). A p value less than .05 assumed significance.
RESULTS
Histology and Immunohistochemistry
On tissue sections obtained from a patient undergoing a total
knee replacement, adipocytes appeared pale as the lipid they
contained was dissolved during tissue processing. The remaining
cellmembranes had amesh-like appearance. Small capillaries ran
between these cell membranes, with larger vessels, with walls
containingsmoothmuscle, interspersedthroughout theadipocytes.
Figure 3. Flowcytometry isolationof perivascular stemcells. (A): Fluorescence-activated cell sorting imagesdemonstrate thegating strategyused to
isolateperivascular stemcells. Events likely to represent single cellswere selectedon their size and relativedimensions, followedbydeadcell exclusion
using 49,6-diamidino-2-phenylindole (DAPI; top row). Endothelial cells and hematopoietic stem cells were excluded based on expression of CD31 and
CD45, respectively (bottom left). Gates used to select pericytes (CD146+CD342) and adventitial cells (CD1462CD34+; bottommiddle)were basedon
isotype controls (bottom right). (B):Mean number of pericytes, adventitial cells, and perivascular stem cells sorted using fluorescence-activated cell
sorting from patients undergoing ACL reconstruction or TKR were compared. (C): The number of cells sorted per gram of tissue were compared be-
tween patients undergoing ACL reconstruction or TKR. (D): The percentage of the live cells from the stromal vascular fraction that were pericytes or
adventitial cellswerecompared.Abbreviations:ACL, anteriorcruciate ligament;APC,allophycocyanin;Cy7,cyanine7;FITC, fluorescein isothiocyanate;
PE, phycoerythrin; SSC-A, side scatter-area; SSC-H, side scatter-height; TKR, total knee replacement.
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The synovial membrane was situated at the right-hand side of the
tissue (Fig. 2I). The synovium was villous and contained numerous
synoviocytes at its surface with a rich supply of blood vessels. The
sections stainedwithPicrosirius red showedcollagens concentrated
around the larger blood vessels (Fig. 2H).
Tissue sections fromthe samesamplewereused todocument
the in vivo location of perivascular cell markers in relation to each
other and endothelial cell markers in the infrapatellar fat pad (Fig.
2A–2G).CD31andvWFwereusedasendothelial cellmarkers. CD146
staining was adjacent and abluminal to the CD31 staining. CD34 was
also foundadjacentandabluminal to theCD146stainingandwasalso
coexpressed with CD31 on the endothelium. The perivascular loca-
tion of NG2 and PDGFRb staining was also confirmed. The anti-
PDGFRb antibody stained the adventitia similar to anti-CD34 but
not the endothelium. Controls imaged under identical conditions
for each of the antibodies did not demonstrate any positive staining
Cell Analysis and Sorting; Variations With Patient
Demographics and Conditions
An initial FACS analysis of the stromal vascular fractions of the IFP
from patients undergoing total knee arthroplasty and arthro-
scopic fat pad debridement demonstrated the presence of both
pericytes and adventitial cells. The analysis from a patient under-
going a knee replacement is shown in Figure 3. Initial gating used
the forward and side-scatter profiles to select individual cells of
the appropriate size and granularity. DAPI was used to exclude
dead cells. The tissue processing and analysis were conducted
with minimal delay (less than 4 hours from harvest), and the cell via-
bility was 97%. Anti-CD31 and CD45 antibodies were used to label
endothelial and hematopoietic cells, respectively; only cells negative
to both antibodies were gated for further analysis. Pericytes and ad-
ventitialcellswerethenselectedontheexpressionofCD146andCD34
(pericytes CD146+CD342 and adventitial cells CD1462CD34+). Neg-
ative controls were used to set the level of true-positive staining for
each of the fluorophores; an unstained sample is shown to demon-
strate where these gates were set (Fig. 4A, bottom right plot).
In addition to the 2 analyses, perivascular stemcellswerepro-
spectively isolated from 23 patients using fluorescence-activated
cell sorting. Thirteen were from patients undergoing TKRs and 10
were arthroscopically collected during ACL reconstruction. The
patients’ mean age (6SEM) was 52.4 6 4.4 years (TKR, 68.1 6
3.1 years; ACL, 31.9 6 3.3 years); mean body mass index was
31.9 6 1.6 kg/m2 (TKR, 36.0 6 2.0 kg/m2; ACL, 27.4 6 1.8 kg/m2).
There were 12 male patients and 11 female patients (male-to-
female ratios: TKR, 4:9, ACL 8:2). The ACL patients were significantly
youngerandhada lowerBMIthanpatients in theTKRgroup(indepen-
dent t test, p, .001 and p = .005, respectively). There was also a sig-
nificant difference in sex (chi-square test, p = .035).
The data on the amount of harvested tissue and the number
and percentages of PSCs harvested are displayed in Table 1 and
Figure 3. Although there was a numerical difference in the mass
of tissue harvested by the twomethods, this did not reach statistical
significance (p= .066). Thenumbersof pericytes andadventitial cells
weregreater in the samples collected frompatientsundergoingTKR,
although this only reached statistical significance for the adventitial
cells andwhen the cellswere combined. To ensure that these differ-
enceswerenot relatedto themassof tissuecollected, thenumberof
cells sortedper gramwas also analyzed anddemonstrated the same
pattern as the results for the total number of cells.
Table 1. Patient demographics and fluorescence-activated cell sorting data
Characteristic TKR patients ACL patients All patients
Age (years) 68.16 3.1 31.96 3.3 52.46 4.4
BMI 36.06 2.0 27.46 1.8 31.96 1.6
Sex, no.
Male 4 8 12
Female 9 2 11
Laterality, no.
Right 10 7 17
Left 3 3 6
Tissue mass harvested (g) 8.0 6 0.7 11.06 1.4 9.3 6 0.8
Total no. of sorted cells
collected
Pericytes 7.5 6 3.73 104 0.8 6 0.33 104 4.6 6 2.23 104
Adventitial cells 23.56 4.13 104 65.06 3.03 104 16.26 3.23 104
Total PSCs 31.06 6.13 104 7.3 6 3.63 104 20.76 4.63 104
No. cells per gram tissue
Pericytes 13.36 7.73 103 0.8 6 0.33 103 7.9 6 4.43 103
Adventitial cells 31.46 5.63 103 6.9 6 3.33 103 20.86 4.33 103
Total PSCs 44.86 11.63 103 7.8 6 3.73 103 28.76 7.73 103
Percentage of live cells
Pericytes 4.0 6 1.2 3.5 6 0.6 3.8 6 0.7
Adventitial cells 18.46 4.0 25.06 4.7 21.26 3.0
Total PSCs 22.56 3.8 28.56 4.8 25.16 3.0
Data given as mean6 SEM unless otherwise indicated.
Abbreviations: ACL, anterior cruciate ligament reconstruction; BMI, body mass index; PSC, perivascular stem cell; TKR, total knee replacement.
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Phenotype of Cultured Perivascular Stem Cells
Cells were purified using FACS and cultured for between four and
six passages in monolayer culture before analysis. Single cells
were gated andhistograms of each antibodywere comparedwith
the relevant isotype control (Fig. 4). Endothelial, hematopoietic,
and myogenic cell markers were all absent (CD144, CD45, and
CD56 respectively; data not shown). Each of the cell types was
positive for the MSC markers CD44, CD90, and CD105. CD34 is
not expressed in cultured cells and was absent in all of the tested
groups. CD146 is normally expressed by pericytes and late-
passage adventitial cells (unpublished data) but was absent in
all of the groups. The compensation beads used to set up the ex-
periment hadbeen strongly positive, demonstrating that the anti-
CD146 antibody was working and the FACS was set up correctly.
Subsequent analysis of cultured pericytes (passages 4–6) from 5
separate patients did not demonstrate any CD146 expression
compared with isotype controls (data not shown).
Cultured pericytes demonstrated expression of CD146, NG2, and
PDGFRbwith immunocytochemistry, comparedwithcontrols (Fig.4).
ExtractedRNAwas reverse transcribedanddemonstratedexpression
of CD146, NG2, andPDGFRb on gel electrophoresis after PCR (Fig. 4).
The RNA-free control as well as the CD31, CD34, and CD45 reactions
were all negative. This demonstrated that cultured pericytes were
CD146+ by immunocytochemistry and PCR, but not by FACS.
Osteogenic and Adipogenic Differentiation
Cultured pericytes, adventitial cells, and mixed PSCs, from both ACL
and TKR samples, all exhibited osteogenic, adipogenic, and chondro-
genic potentials. Osteogenic differentiation was confirmed with
functional staining with Alizarin red for calcium deposition and with
Figure4. Characterizationofculturedperivascularstemcells. (A):Culturedpericytes,adventitialcells,andmixedperivascularstemcellswereanalyzed
for expression of mesenchymal and PSCs markers using flow cytometry; left to right: CD44, CD90, CD105, CD146, CD34. (B): Cultured pericytes were
analyzed using immunocytochemistry for antibodies associated with pericytes (top row). Controls omitted the primary antibodies (bottom row). (C):
Cultured pericytes were genotyped using reverse transcription polymerase chain reaction. Scale bar = 400 mm. Abbreviations: FITC, fluorescein iso-
thiocyanate; NG2, neural/glial antigen 2; PDGFRb, platelet-derived growth factor receptor-b; PE, phycoerythrin; PSC, perivascular stem cell.
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geneticexpressionofrunx-2,ALPL,andBGLAPconfirmedonPCR(Fig.
5). Adipogenic potential was confirmed by intracellular uptake of Oil
Red O in lipid vacuoles and genetic expression of pPARg (Fig. 5).
Chondrogenic Potential of PSCs From IFP Compared
With That of MSCs
Chondrogenic differentiation was confirmed with histochemical
stains of proteoglycans with Alcian blue and collagens with Picro-
sirius red (Fig. 6). A cartilage pelletmodel demonstrated that both
the IFP PSCs andMSCs generated significantly more extracellular
matrix than bone marrow-derived MSCs (p, .001 and p = .011,
respectively; Fig. 6). Pericytes, adventitial cells, and combined
PSCs were compared with adipose-derived MSCs (also known
as adipose-derived stem cells [ASCs]) and bone marrow-derived
MSCs (BM-MSCs). Each cell type was cultured using growth me-
dium (Fig. 6F, left columns) and chondrogenic medium (Fig. 6F,
right-hand columns). The PSCs generated significantly more ex-
tracellular matrix than the IFP MSCs (ASCs; p = .002).
Amicromass culture demonstrated clear Alcian blue and Picrosir-
ius red stainingonsections, indicating theproductionofproteoglycans
andcollagens(Fig.6).qPCRshowedthatdifferentiatedPSCswereupre-
gulatedcomparedwithMSCs forCOL2A1,ACAN, andSOX9expression
by factors of 4.86 1.3, 4.36 0.9, and 7.06 1.7, respectively (Fig. 6).
DISCUSSION
This research has accurately identified pericytes and adventitial cells
within the human infrapatellar fat pad. Previous identification of peri-
cytes within the IFP used a monoclonal anti-3G5 antibody, which
stained the tunica adventitia of a small arteriole [11]. Pericytes are clas-
sically described as being found around smaller vessels [1]; the histo-
chemical staining presented by Khan et al. was similar to the peri-
arteriolar reactivity we observed with an antibody to a-SMA (Fig.
2A). The immunohistochemistry in Figure 2B clearly demonstrated
CD146 staining around the endothelium of a microvessel, in keeping
with pericytes. Figure 2E and 2F shows that the pericyte staining was
separate from the tunica adventitia where the adventitial cells are lo-
cated.Ourdataconfirmedtheperivascular locationofpericytesandad-
ventitial cellswithin the IFPandthat theyweredistinct cell populations.
CD146was normally expressed by IFP pericytes in situ (Fig. 2) and
following cell dissociation (Fig. 3), but by only extremely few cultured
IFPpericytes (Fig. 4).Wedonothaveadefinitive interpretation for this
observation,whichwehavemadesporadically,whereasCD146expres-
sion is generally sustained in vitro. For additional information, the
reader isreferredtothepaperbyCrisanetal. [1].Apossibleexplanation
is that CD146, being a cell adhesionmolecule, exhibits variable expres-
sion depending on cell density or confluence in the culture flask. It is
known that state of confluence influences the expression ofmany cell
surfacemarkers in cultures of human bonemarrow stromal cells [20].
There is no consensus on the optimal tissue for harvesting stem
cells for cartilage repair and regeneration procedures. Themost com-
monly used in registered clinical trials are bone marrow-derived
MSCs. Bone marrow has demonstrated superiority over subcutane-
ous fat in two studies [21, 22] but no difference in another [23],
and synovium has demonstrated superiority over bone marrow
[24]. Neither of these has been compared with adipose tissue from
the infrapatellar fat pad, which has demonstrated superiority over
Figure 5. Osteogenic and adipogenic differentiation. (A):Osteogenic differentiation of PSC demonstrated increased Alizarin Red staining com-
paredwithMSC controls. (B):Adipogenic differentiation of PSCs andMSCs demonstrated increased intracellular vesicles comparedwith growth
media controls,which stainedpositive forOil RedO. (C):Differentiated cells expressedRUNX2,ALPL, andBGLAP;ACTBwasusedas the reference
gene. (D): Differentiated cells expressed PPARG; ACTBwas used as the reference gene. Scale bar = 50 mm. Channels used in polymerase chain
reaction images, left to right: 1, anterior cruciate ligament (ACL) pericytes; 2, ACL adventitial cells; 3, ACLmixed PSCs; 4, total knee replacement
(TKR) pericytes; 5, TKR adventitial cells; 6, TKRmixed PSCs; 7, ACLMSCs; 8, TKRMSCs; 9, bone-marrow-derivedMSCs; 10, complementary deox-
yribonucleic acid negative control. Abbreviations: MSC, mesenchymal stem cell; PSC, perivascular stem cell.
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subcutaneous fat [15]. Lopa et al. used culture-derived MSCs with
no cell purification or isolation [15]. Our data agreed that the IFP
was a superior source of stem cells (PSCs or MSCs) compared with
bonemarrow (Fig. 6F). Furthermore,whenwe compared PSCswith
MSCs from the IFP using relative genetic expression, we found that
therewas an advantage to isolating PSCs using flowcytometry com-
paredwith derivingMSCs from culture of the stromal vascular frac-
tion (Fig. 6G–6J). The increase in relative genetic expression of
chondrogenic cell markers was consistent with other studies that
have found significant differences when comparing cell sources
for chondrogenic differentiation [15].
Articlesthathaveadvocatedsynoviumasasourceofregenerative
cells havenot includedhistologyor characterization to indicatewhich
cells were being used [25]. The histology and immunohistochemistry
images in this study demonstrated how narrow the synovium is and
howhard itwouldbe tophysicallyharvestonly synovial tissueandnot
theunderlying tissue. The immunohistochemistrydemonstrated that
thesynoviumhasarichvascularsupplypopulatedwithPSCs.Ourdata
suggest that synovium-derivedMSCs originate from these perivascu-
lar cells. The synovium is thought to play an active role in immuno-
modulation within the knee, particularly in osteoarthritis [26]. The
utility of cells from the synovium is in keeping with Caplan’s theory
thatMSCswork by growth factor and cytokine secretion rather than
engraftment and differentiation [27, 28].
We have isolated pericytes and adventitial cells from IFPs as dis-
tinct populations for culture, analysis, and differentiation. The cells
were also combined immediately after isolation and cultured to-
gether to investigatewhether therewasasynergistic effect, because
the two populations are found in close proximity in vivo. No clear
distinctionwasdemonstratedduringouranalysis,butduring thecar-
tilage pellet formation, the coculture produced significantly larger
pellets than thepericytesoradventitial cells cultured individually.Al-
though these are distinctly different cells, this synergistic effect
would prove an interesting subject for further investigation.
Approximately six to eight culture passages were required to
get a sufficient number of cells to complete the PSC identity work
and the differentiation experiments. This means that the PSCs
were fromhigher-passagecultures thantheMSCs,whichwerealways
used at passage 2. This difference would theoretically disadvantage
the PSCs in this comparison, suggesting a greater advantage of PSCS
overMSCs if used at a comparable passage number. Approximately 1
3106cellspercm2areusedforautologouschondrocyte implantation
[29] and commercial companies typically use passage3 chondrocytes
[30].ProliferationofautologousPSCsfromtheIFPtoclinicallyrelevant
numbers would likely require the same number of passages.
Our data also demonstrated that it is possible to obtain viable
cells from tissue that has been harvested arthroscopically. This
means that orthopedic surgeons canharvest adipose tissue samples
Figure 6. Chondrogenic differentiation of PSCs. Chondrogenesis was confirmedusing pellet (A, B) andmicromass (C, D)models indicated byAlcian Blue
staining (A,C) forsulfatedproteoglycansandPicrosiriusRed (B,D) forcollagens IandII. (E):Macroscopicdifferenceinappearanceisseenbetweenthepellets
(whitearrow)andmicromasses (pinkarrow). (F):PSCscreatedsignificantly largerpelletscomparedwithmesenchymal stemcells fromthe fatpadandbone
marrow.Relativegeneticexpressionofchondrogenicmarkers indicatedthat infrapatellar fatpad(IFP)PSCshadgreaterexpressionofCOL2A1 (G), SOX9 (H),
andACAN (I), aswellasan increasedratioofCOL2A1toCOL1A1 (J)comparedwith IFPMSCs.Scalebar=400mm (A–D).Abbreviations:Adv,adventitial;ASC,
adipose-derived stem cell; BM-MSC, bone marrow-derived mesenchymal stem cell; PSC, perivascular stem cell; PSR, Picrosirius red stain.
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without the need for liposuction and could either electively plan to
collect IFPusingminimally invasivearthroscopy,orharvest tissueop-
portunistically while performing arthroscopy for another reason.
There aremore than 20 clinical trials usingMSCs for articular car-
tilage damage registered with the ClinicalTrials.gov website [31]. Our
data suggest that PSCs are, in fact, superior toMSCs and that current
clinical trials are using suboptimal, uncharacterized cells, whichmight
be a reason for the heterogeneous results reported in the literature
withanimalandhumanstudies[32].Furtherwork is requiredtodefine
the optimal cells and their preparation for chondrogenesis if transla-
tion to patients is to be given the best chance of being effective.
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